Novo Nordisk conducts two-for-one stock split

Novo Nordisk stated: “As communicated on 10 August 2023 in connection with the release of Novo Nordisk’s financial results for the first six months of 2023, Novo Nordisk’s Board of Directors has approved a split of the trading units of the Novo Nordisk B shares listed on Nasdaq Copenhagen and of the American Depositary Receipts (ADRs) listed on New York Stock Exchange in a two-for-one ratio. Novo Nordisk’s B shares have been listed on Nasdaq Copenhagen in trading units of DKK 0.20 and its American Depositary Receipts that equal B-shares of DKK 0.20 have been listed on New York Stock Exchange. Consequently, the trading unit of the Novo Nordisk B shares listed on Nasdaq Copenhagen has been changed from DKK 0.20 to DKK 0.10 as of 13 September 2023. The ADRs will similarly be split as of 20 September 2023 to maintain the one-to-one relationship between the B-share and the ADR.”